Skip to content

Released Aug 13, 2021, before the open

10-Q filed Aug 13, 2021, 44 days after period end · 0001493152-21-019696

Q2 2021 · 10-Q
Revenue$9.14M+152.3% vs Q2 2020−40.1% vs Q1 2021
Net Income-$1.40MN/M vs Q2 2020N/M vs Q1 2021
EPS Diluted-$0.09N/M vs Q2 2020N/M vs Q1 2021
Gross Profit$4,466,000+249.2%
Operating Income-$1,450,000N/M
Operating Cash Flowderived$4,442,000+1.6%
Free Cash Flowderived$4,132,000−4.8%
Margins · derived
Gross margin48.9%+13.5 pt vs Q2 2020
Operating margin-15.9%−17.5 pt vs Q2 2020
Net margin-15.3%−17.2 pt vs Q2 2020

What the release said

The release

Same quarter

MetricQ2 2021Q2 2020Q2 2019Q2 2018
Revenue$9.14M$3.62M$1.65M$3.19M
Net Income-$1.40M$70.00K-$1.24M-$259.00K
EPS Diluted-$0.09$0.01-$0.11-$0.02

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR